قالب وردپرس درنا توس
Home / Business / The company that develops the COVID-19 rapid diagnostic test will expand its operations

The company that develops the COVID-19 rapid diagnostic test will expand its operations



A Pennsylvania company that is conducting a quick diagnostic test for COVID-19 will expand its production. Tom Wolf made the announcement Tuesday morning about OraSure Technologies Inc., headquartered in Northampton County. Company-developed testing will allow individuals to easily collect samples and read results on their own shortly thereafter. “OraQuick coronavirus rapid antigen self-test will quickly detect active COVID-19 infection at the sampling point without the need for instrumentation to interpret the results and no need to transport the sample to the lab for analysis. It’s basically the lab on a swab, “said OraSure President and CEO Stephen S. Tang:”

; It’s important because this will add to our ability to do contemporary testing. Fast turnaround times for Pennsylvanians. This could help us in the future as we move towards the new normal, “Wolf said. The rapid test could be approved by the Food and Drug Administration later this year. development of a lab-based antibody test to detect previous COVID-19 infection.OraSure expansion will create 177 production jobs at the company’s four Bethlehem sites creating new jobs.

A Pennsylvania company that is conducting a quick diagnostic test for COVID-19 will expand its production.

Governor Tom Wolf made the announcement Tuesday morning about OraSure Technologies Inc., headquartered in Northampton County.

Company-developed testing will allow individuals to easily sample and read results on their own shortly thereafter.

“The OraQuick coronavirus rapid antigen self-test will quickly detect active COVID-19 infection at the sampling point without the need for instrumentation to interpret the results and no need to transport the sample to the lab for analysis. It’s basically the swab lab, ”said OraSure President and CEO Stephen S. Tang.

“It is important because this will further increase our ability to test the turnaround times for the Pennsylvanians. This could help us in the future as we move towards moderation,” Wolf said. usually new “.

The company hopes the quick test can be approved by the Food and Drug Administration by the end of this year.

OraSure is also developing a laboratory-based antibody test to detect previous COVID-19 infection.

Officials say the OraSure expansion will create 177 manufacturing jobs at the company’s four locations in Bethlehem.

According to the Wolf administration, OraSure received a grant proposal from the Department of Community and Economic Development with a grant of $ 531,000 Pennsylvania First and $ 531,000 in Job Creation Tax Credits that will be allocated when creating new jobs.


Source link